Condition
Ocular Myasthenia Gravis clinical trials and research
Research outlook What's coming for Myasthenia gravis: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 4 Ocular Myasthenia Gravis clinical trials that are recruiting, at sites in 9 countries (most in China (3), France (3), Georgia (2)). By phase: Phase 3 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 9Countries
Newest Ocular Myasthenia Gravis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Rozanolixizumab for long-term safety and efficacy in adult ocular myasthenia gravis | Phase 3 | Scottsdale, Arizona and 17 other locations | Recruiting | Mar 11, 2026 |
| Rozanolixizumab for adult ocular myasthenia gravis | Phase 3 | Scottsdale, Arizona and 35 other locations | Recruiting | Mar 11, 2026 |
| Immediate corticosteroids with rituximab as needed to stop ocular myasthenia from spreading | Phase 3 | Bordeaux and 10 other locations | Recruiting | Apr 2, 2024 |
| Different immunosuppressants and treatments for new-onset ocular myasthenia gravis | — | Xi'an, Shaanxi | Recruiting | Dec 2, 2019 |
All recruiting trials (4)
-
Rozanolixizumab for long-term safety and efficacy in adult ocular myasthenia gravis
This study tests whether Rozanolixizumab is safe and helps adults with ocular myasthenia gravis over the long term.
-
Rozanolixizumab for adult ocular myasthenia gravis
This trial tests Rozanolixizumab versus placebo to see if it helps adults with ocular myasthenia gravis see improvements in eye muscles with tolerable safety.
-
Immediate corticosteroids with rituximab as needed to stop ocular myasthenia from spreading
We will test whether starting corticosteroids right away, and adding rituximab if eye symptoms come back, can prevent recent-onset ocular myasthenia from spreading to other muscles in adults.
-
Different immunosuppressants and treatments for new-onset ocular myasthenia gravis
This project tries different immunosuppressants and symptomatic treatments to see which works best and is safest for adults with new-onset ocular myasthenia gravis.
Related topics
Quick answers
How many Ocular Myasthenia Gravis clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in China (3 trials), France (3 trials), Georgia (2 trials), Japan (2 trials), Poland (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.